Men’s Health Medications
Men’s health medicines in this category focus mainly on male pattern hair loss and urinary symptoms linked to benign prostatic hyperplasia. Comparing them is easier when you separate prostate relaxation, prostate-size reduction, and scalp hair-growth support.
Avodart
0.5mg
Developed to alleviate symptoms of prostate enlargement, indicated to target hormone-related hair loss and support prostate function relief.
Bicalutamide Tablets
50mg
Developed to target prostate cancer activity, this medication is indicated to support the management of androgen-dependent disease progression in adult males.
Dutas
0.5mg
developed to alleviate symptoms of prostatic enlargement and to target androgen-dependent hormone changes.
Dutasteride Capsules
0.5mg
Formulated to target androgen-dependent hair loss and prostate enlargement by blocking the conversion of testosterone, intended to support healthy hair regrowth and prostate function.
Finasteride Tablets
1mg
Indicated to support to mitigate hair loss progression, developed to target hormonal factors affecting hair growth in male patients.
Flomax
0.2 · 0.4mg
Utilized to relieve urinary symptoms of benign prostatic hyperplasia, intended to support improved flow by relaxing smooth muscle in the prostate.
Jalyn
0.4/0.5mg
Developed to alleviate benign prostatic hyperplasia symptoms to support urinary flow.
Minoxidil Tablets
5 · 10mg
Indicated to mitigate high blood pressure, utilized to support systemic vascular health.
Propecia
1 · 5mg
Indicated to manage male pattern hair loss, formulated to target hormonal conversion and support follicle retention.
Tamsulosin Tablets
0.2 · 0.4mg
This medicine is intended to manage urinary symptoms associated with prostate enlargement, formulated to support urine flow and to alleviate frequent urination.
Terazosin Tablets
1 · 2 · 5mg
These tablets are indicated to alleviate outlet obstruction and utilized to support urinary flow in men with prostate enlargement.
What this category helps you sort out
The same hormone pathway can show up in different places. Dihydrotestosterone can contribute to scalp hair miniaturisation and prostate enlargement, but the treatment goal and risk discussion are not the same.
Urinary symptoms such as weak flow, hesitancy, night-time urination, or incomplete emptying should be understood in context, especially when symptoms are new, severe, or associated with pain or blood.
How to compare options
- Identify the goal: hair preservation, urinary flow improvement, prostate-size reduction, or symptom relief.
- Check time to benefit; prostate-size and hair-loss medicines can take months to judge.
- Review sexual side effects, dizziness, blood pressure effects, fertility plans, and prostate cancer screening implications.
- Seek assessment for blood in urine, urinary retention, fever, pelvic pain, or unexplained weight loss.
Common medication groups
5-alpha reductase inhibitors
These reduce conversion of testosterone to DHT and may be used for pattern hair loss or enlarged prostate depending on the product and dose. They require clear pregnancy-handling precautions and side-effect discussion.
Alpha blockers
Alpha blockers relax smooth muscle around the prostate and bladder neck to improve urine flow. Dizziness, low blood pressure, and timing around cataract surgery are common safety checks.
Minoxidil formulations
Minoxidil supports hair growth through effects on the hair cycle. Topical use needs consistency and can irritate the scalp; oral use has cardiovascular considerations.
Safety notes for this category
New urinary symptoms should not automatically be assumed to be benign prostate enlargement. Infection, stones, neurological causes, and cancer screening questions may need review.
Tell a clinician about erectile dysfunction medicines, blood pressure medicines, cataract surgery plans, fertility goals, and prostate-specific antigen testing.
Important Safety Information
Men’s health products differ by target, timeline, and monitoring needs. This page is educational and does not replace prostate assessment, hair-loss diagnosis, or product-specific labeling.